Pharmafile Logo

KOL Strategy

- PMLiVE

Eisai and Biogen’s new data shows Alzheimer’s patients choose to stay on Leqembi long-term

The findings were presented at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases in Denmark

- PMLiVE

PRGN adds OVID Health as Specialist Healthcare Member Agency

OVID Health joins PRGN, boosting patient-centred healthcare and life science communications

Grace Communications logo

GRACE COMMS acquisition of WORDBIRD creates a merger of two independent, strategic and creative healthcare agencies

We are delighted to announce that Grace Comms and Wordbird Limited, both healthcare brand comms agencies with a creative mission in healthcare and a passion for people, are coming together....

Grace Communications

- PMLiVE

Scotland becomes first part of UK to screen all newborn babies for SMA

The screening is part of a two-year evaluation funded by the Scottish government and Novartis

- PMLiVE

RedSail Technologies appoints Joy Neely as Chief Growth Officer

Neely previously worked at Medvantx, Roche and Eli Lilly

- PMLiVE

Novartis agrees on potential $3bn deal to buy Synnovations’s breast cancer treatment

The oral drug is currently being evaluated for breast cancer and other advanced solid tumours in a phase 1/2 study

- PMLiVE

Prime appoints David Hogben as SVP, Omnichannel Strategy & Delivery

Hogben has previously worked across the US and global markets

- PMLiVE

Leading with Heart: Why Vulnerability is a Force Multiplier

In a world that often prizes "macho" decisiveness, Dr. Lobna Salem (CMO at Viatris) and Dr. Amrit Ray (Board Chairman and former Pfizer executive) are advocating for a more human...

Medscape Education

- PMLiVE

Department of Health and Social Care and partners launch new funding initiative

The DHSC, along with a UK government department and Wellcome, aims to tackle urgent infectious disease threats

- PMLiVE

Biologos appoints Hetal Patel as CEO

The appointment coincides with Biologos’ 50th anniversary

- PMLiVE

Almirall celebrates new offices in China to advance innovation in dermatology

The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links